Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1 Phase 1 1

Status

Completed 26 Unknown 11 Recruiting 5 Not yet recruiting 2 Withdrawn 1 Terminated 1 Enrolling by invitation 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 120 Neoplasms 75 Prostatic Neoplasms 70 Lung Neoplasms 36 Carcinoma, Non-Small-Cell Lung 33 Pancreatic Neoplasms 32 Colorectal Neoplasms 32 Head and Neck Neoplasms 29 Carcinoma, Hepatocellular 24 Brain Neoplasms 24 Colonic Neoplasms 22 Motor Activity 19 Carcinoma, Renal Cell 18 Pain 16 Ovarian Neoplasms 16 Neoplasm Metastasis 14 Hematologic Neoplasms 14 Urinary Bladder Neoplasms 13 Rectal Neoplasms 13 Lymphoma, Follicular 13 Fatigue 13 Sarcoma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Glioblastoma 12 Lymphoma 11 Liver Neoplasms 11 Glioma 11 Squamous Cell Carcinoma of Head and Neck 10 Leukemia 10 Anxiety Disorders 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Withdrawn × Myofibroma × Clear all

NCT01735812 2022-06-13

UFREEZE-01

IceCure Medical Ltd.

Phase NA Withdrawn

Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡